Baricitinib: JAHO/JAIR - BRAVE Trial Program
BRAVE-AA1 is a Phase 2b/3 Clinical Trial in Adults with Severe Alopecia Areata (> 50% Scalp Loss).
Please access the following to view the full trial information: ClinicalTrials.gov (BRAVE-AA1)
Please access the following to view the full trial information: ClinicalTrials.gov (BRAVE-AA1)
- Individual results may vary.
- Patient hairstyles, individual characteristics, image angles, lighting and other variables may influence the appearance of SALT scores.
For questions or to report an Adverse Event or Product complaint, please contact 1-800-LILLYRX (1-800-545-5979).